Print-ready dossier — use your browser's print dialog to save as PDF.
ACCU-CHEK AVIVA PLUS
Model 06908420002 · Roche Diagnostics Operations, Inc. · DI 00365702700932
LFR — Glucose Dehydrogenase, Glucose · Class II · 21 CFR 862.1345
UDILibrary device dossier · generated 2026-09-15 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (0)
No recalls linked in the loaded window.
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
Monthly adverse-event reports for this device versus the product-code average.
Month
This device (reports)
Product-code average (reports per device)
2019-01
0
8.87
2019-02
0
10
2019-03
0
9.14
2019-04
0
13.35
2019-05
0
11.61
2019-06
0
11.16
2019-07
0
11.37
2019-08
0
11.23
2019-09
0
9.05
2019-10
0
9.22
2019-11
0
7.09
2019-12
0
5.97
2020-01
0
8.74
2020-02
0
7.36
2020-03
0
7.88
2020-04
0
7.33
2020-05
0
8.65
2020-06
0
8.05
2020-07
0
6.97
2020-08
0
4.44
2020-09
0
9.55
2020-10
0
5.03
2020-11
0
7.15
2020-12
0
7.11
2021-01
0
9.11
2021-02
0
7.95
2021-03
0
7.12
2021-04
0
8.16
2021-05
0
5.87
2021-06
0
7.26
2021-07
0
8.31
2021-08
0
8.96
2021-09
0
8.24
2021-10
0
8.24
2021-11
0
8.87
2021-12
0
9.97
2022-01
0
8.46
2022-02
0
7.61
2022-03
0
9.07
2022-04
0
8.69
2022-05
0
7.15
2022-06
0
6.51
2022-07
0
7.8
2022-08
0
3.58
2022-09
0
4.01
2022-10
0
3.88
2022-11
0
8.03
2022-12
0
3.85
2023-01
0
6.97
2023-02
0
5.46
2023-03
0
4.71
2023-04
0
2.97
2023-05
0
4.28
2023-06
0
3.85
2023-07
0
3.28
2023-08
0
4.91
2023-09
0
2.62
2023-10
0
2.92
2023-11
0
2.86
2023-12
0
2.54
2024-01
0
5.41
2024-02
0
2.44
2024-03
0
5.41
2024-04
0
3.01
2024-05
0
4.45
2024-06
0
3.52
2024-07
0
2.43
2024-08
0
2.34
2024-09
0
2.97
2024-10
0
3.97
2024-11
0
2.4
2024-12
0
4.28
2025-01
0
5.77
2025-02
0
2.22
2025-03
0
2.47
2025-04
0
4.3
2025-05
0
5.09
2025-06
0
2.26
2025-07
0
2.06
2025-08
0
4.08
2025-09
0
2.55
2025-10
0
3.37
2025-11
0
3.2
2025-12
0
3.83
2026-01
0
4.64
2026-02
0
2.34
2026-03
0
5.13
2026-04
0
5.43
2026-05
0
4.09
2026-06
0
6.93
This device (reports/month)Average device in LFR (reports/device/month)
Regulatory clearances
None linked in the loaded window.
Manufacturer compliance record — Roche Diagnostics Operations, Inc.
NAI 2023-11-30 Roche Molecular Systems, Inc. · 0 citations
NAI 2022-12-07 Roche Diagnostics Operations, Inc. · 0 citations
NAI 2022-09-23 Ventana Medical Systems, Inc. · 0 citations
NAI 2022-09-15 Ventana Medical Systems, Inc. · 0 citations
NAI 2021-07-29 Ventana Medical Systems, Inc. · 0 citations
NAI 2020-02-26 Ventana Medical Systems, Inc. · 0 citations
VAI 2019-08-29 Roche Diagnostics GmbH · 0 citations
NAI 2019-08-14 Ventana Medical Systems, Inc. · 0 citations
VAI 2019-07-25 Roche Diabetes Care, Inc. · 3 citations
VAI 2019-06-27 Roche Diagnostics Operations, Inc. · 1 citations
NAI 2018-04-19 Roche Diagnostics GmbH · 0 citations
NAI 2018-04-12 Roche Diagnostics GmbH · 0 citations
NAI 2017-07-24 Roche Molecular Systems, Inc. · 0 citations
NAI 2017-07-13 Ventana Medical Systems, Inc. · 0 citations
NAI 2017-02-27 Roche Molecular Systems, Inc. · 0 citations
VAI 2017-02-02 Roche Diabetes Care GmbH · 1 citations
NAI 2016-11-18 Roche Diagnostics GmbH · 0 citations
NAI 2016-10-14 Roche Diagnostics Operations, Inc. · 0 citations
NAI 2016-09-01 Roche Molecular Systems, Inc. · 0 citations
VAI 2016-08-15 Roche Diagnostics Operations, Inc. · 1 citations